{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T08:40:23Z","timestamp":1691916023382},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.yexmp.2015.08.006","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T03:15:17Z","timestamp":1440040517000},"page":"341-343","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy"],"prefix":"10.1016","volume":"99","author":[{"given":"Christina H.","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Penunuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Karpouzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Fleishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel W.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2015.08.006_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2013.00489","article-title":"Is TWEAK a biomarker for autoimmune\/chronic inflammatory diseases?","volume":"4","author":"Bertin","year":"2013","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.yexmp.2015.08.006_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4254\/wjh.v2.i11.410","article-title":"Acute liver injury induced by weight-loss herbal supplements","volume":"2","author":"Chen","year":"2010","journal-title":"World J. Hepatol."},{"issue":"5402","key":"10.1016\/j.yexmp.2015.08.006_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.283.5402.649","article-title":"Costimulation: building an immunological synapse","volume":"283","author":"Dustin","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.yexmp.2015.08.006_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yexmp.2014.03.003","article-title":"Mechanism of hepatotoxicity due to black cohosh (Cimicifuga racemosa): histological, immunohistochemical and electron microscopy analysis of two liver biopsies with clinical correlation","volume":"96","author":"Enbom","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.yexmp.2015.08.006_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.yexmp.2014.03.009","article-title":"Piecemeal necrosis of the liver revisited a review","volume":"96","author":"French","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.yexmp.2015.08.006_bb0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10067-006-0218-1","article-title":"Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease","volume":"26","author":"Giner Galva\u00f1","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.yexmp.2015.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","article-title":"MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes","volume":"37","author":"Herkel","year":"2003","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.yexmp.2015.08.006_bb0040","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1073\/pnas.142298399","article-title":"CD28 plays a critical role in the segregation of PKC\u03b8 within the immunological synapse","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.yexmp.2015.08.006_bb0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-3468(97)90714-4","article-title":"Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis","volume":"32","author":"Kobayashi","year":"1997","journal-title":"J. Pediatr. Surg."},{"issue":"2","key":"10.1016\/j.yexmp.2015.08.006_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/1078-0432.CCR-14-1334","article-title":"A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers","volume":"21","author":"Lassen","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.08.006_bb0055","doi-asserted-by":"crossref","unstructured":"Nguyen RH, Cruz PD Jr. Hepatitis due to mycophenolate mofetil used to treat atopic dermatitis and allergic contact dermatitis. Dermatitis. 2014;25(5):284\u20135 (Sep\u2013Oct).","DOI":"10.1097\/DER.0000000000000074"},{"issue":"4","key":"10.1016\/j.yexmp.2015.08.006_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.rhu.0000173619.23349.09","article-title":"Basic science for the clinician 30: the immunologic synapse","volume":"11","author":"Sigal","year":"2005","journal-title":"J. Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.yexmp.2015.08.006_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1358\/dot.2009.45.7.1384878","article-title":"Mycophenolate mofetil: an update","volume":"45","author":"Villarroel","year":"2009","journal-title":"Drugs Today (Barc)"},{"issue":"4","key":"10.1016\/j.yexmp.2015.08.006_bb0070","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bph.12337","article-title":"The TWEAK\u2013Fn14 system as a potential drug target","volume":"170","author":"Wajant","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.yexmp.2015.08.006_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/exmp.2001.2397","article-title":"\u201cPiecemeal\u201d necrosis: renamed troxis necrosis","volume":"71","author":"Wang","year":"2001","journal-title":"Exp. Mol. Pathol."},{"issue":"8","key":"10.1016\/j.yexmp.2015.08.006_bb0080","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.clinthera.2013.06.008","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis","volume":"35","author":"Wisniacki","year":"2013","journal-title":"Clin. Ther."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015001689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015001689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T08:21:41Z","timestamp":1691914901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480015001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0014480015001689"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.08.006","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}